Riskpilot← Back to searchSign inGet full accessSalubrious AB
ABActiveOrg 5565929717LerumWholesale of pharmaceutical and medical goods · NACE 4646Est. 20006 employees
Revenue 2024
SEK 22,7M
-10% vs 2023
EBITDA margin
-2.8%
-229% vs 2023
Equity ratio
47.5%
Financial strength
Net profit 2024
SEK -315K
-265% vs 2023
| Revenue | SEK 22,7M | -10% |
| EBITDA | SEK -624K | -229% |
| Net profit | SEK -315K | -265% |
| Total assets | SEK 10,3M | +1% |
| Equity | SEK 4,9M | -9% |
| Employees | 6 | — |
Legal name
Salubrious AB
Org number
5565929717
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 juli 2000
Share capital
SEK 250 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Good, Jan Anders
Company purpose
Bolaget ska bedriva verksamhet som att sälja produkter och tjänster till vårdinrättningar, såsom operation, intensivvård, specialistavdelningar samt hjälpmedelscentraler. Bolaget ska även bedriva förvaltning av och handel med värdepapper för en begränsad och sluten krets av ägare.
Address
Lerum
Phone
+46317104470
Email
info@salubrious.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 24 287 | 23 407 | 23 135 | 23 093 | 19 395 | 25 270 | 22 681 |
| Staff expenses | — | — | — | — | — | — | — | −4 128 | −4 843 | −4 706 |
| EBITDA | −139 | 646 | 740 | 35 | 855 | 2 299 | 2 520 | −1 450 | 485 | −624 |
| Depreciation & amort. | −96 | −103 | −54 | −13 | −15 | −15 | −26 | −32 | −45 | −71 |
| EBIT | −235 | 543 | 686 | 22 | 840 | 2 284 | 2 494 | −1 482 | 440 | −695 |
| Net financials | −130 | −109 | −86 | −82 | −110 | −47 | 3 | −17 | −80 | 68 |
| Profit before tax | 15 | 285 | 338 | 32 | 535 | 1 657 | 1 897 | 46 | 260 | −315 |
| Tax | −11 | −79 | −97 | −29 | −138 | −373 | −425 | −42 | −68 | — |
| Net profit | 4 | 206 | 241 | 3 | 397 | 1 284 | 1 472 | 4 | 191 | −315 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 612 | 7 471 | 7 535 | 7 046 | 7 479 | 7 596 | 9 198 | 9 841 | 10 257 | 10 327 |
| Equity | 2 362 | 2 568 | 2 429 | 2 032 | 2 429 | 3 713 | 5 185 | 5 189 | 5 380 | 4 907 |
| Long-term debt | 2 378 | 2 079 | 2 117 | 2 084 | 2 153 | 0 | 0 | 1 639 | 1 424 | 2 346 |
| Short-term debt | 2 732 | 2 473 | 2 460 | 2 419 | 2 115 | 2 340 | 1 733 | 2 204 | 2 468 | 2 201 |
| Total debt | 5 110 | 4 552 | 4 577 | 4 503 | 4 268 | 2 340 | 1 733 | 3 843 | 3 893 | 4 547 |
EBITDA margin
-2.8%
This company
15.8%
Market median
-118% vs market
20152024
Equity ratio
47.5%
This company
38.2%
Market median
+24% vs market
20152024
Return on equity
-6.4%
This company
18.4%
Market median
-135% vs market
20152024
Net profit margin
-1.4%
This company
8.1%
Market median
-117% vs market
20152024
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
20152024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-09-01 – 2015-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AS | Audit | 2022 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Svenska Good Medical AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svenska Good Medical AB
Salubrious AB Board members of Salubrious AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Stig Arthur Sandquist | Audit | 0 companies |
| Philip Alexander Vilhelmsson | Chief Executive Officer | 0 companies |
| Helena Erika Good | Deputy Board Member | 0 companies |
| Liselotte E Madelaine Kurzwelly | Board of Directors | 0 companies |
| Jan Anders Good | Chairman | 0 companies |